Analytical Data
-
Gene name
PDCL2
- Application
-
Alternative Names
PDCL2Phosducin-like protein 2
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8N4E4
-
Expression Region
1-241 aa
-
AA Sequence
MQDPNEDTEW NDILRDFGIL PPKEESKDEI EEMVLRLQKE AMVKPFEKMT LAQLKEAEDE FDEEDMQAVE TYRKKRLQEW KALKKKQKFG ELREISGNQY VNEVTNAEED VWVIIHLYRS SIPMCLLVNQ HLSLLARKFP ETKFVKAIVN SCIQHYHDNC LPTIFVYKNG QIEAKFIGII ECGGINLKLE ELEWKLAEVG AIQTDLEENP RKDMVDMMVS SIRNTSIHDD SDSSNSDNDT K
-
Molecular Weight
28.0 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PDCL2 (Pseudomonas Dipeptidase-like Protein 2) is a member of the dipeptidase family that plays a crucial role in various biological processes, including peptide metabolism and regulatory pathways. The significance of PDCL2 in cellular functions piqued scientific interest, especially in the context of its potential implications in diseases related to metabolic dysregulation and immune response. The study of PDCL2 has gained momentum due to its structural and functional similarities with other known peptidases, which suggests it may possess unique enzymatic properties that can be harnessed for therapeutic applications. The recombinant expression of PDCL2 allows for the detailed investigation of its enzymatic activity, substrate specificity, and potential interactions with other biomolecules. Techniques such as molecular cloning and protein expression systems enable the production of PDCL2 in significant quantities, facilitating functional assays and structural studies. Understanding the biochemistry of PDCL2 through recombinant proteins could lead to novel insights into its role in health and disease, and may offer avenues for the development of new drugs or therapeutic strategies targeting metabolic disorders, autoimmune diseases, and other related conditions. As such, the exploration of PDCL2 through recombinant protein research stands at the intersection of biochemistry and applied biomedical science, promising to enhance our understanding of this molecule's implications in human health.
